Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer - Aix-Marseille Université Access content directly
Journal Articles Cancers Year : 2022

Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer

Mathieu Chocry
  • Function : Author
Ludovic Leloup
Fabrice Parat
Mélissa Messé
  • Function : Author
Alessandra Pagano
Hervé Kovacic


Resistance to treatments is one of the leading causes of cancer therapy failure. Oxaliplatin is a standard chemotherapy used to treat metastatic colorectal cancer. However, its efficacy is greatly reduced by the development of resistances. In a previous study, we deciphered the mechanisms leading to oxaliplatin resistance and highlighted the roles played by ROS production and the p38 MAPK pathway in this phenomenon. In this report, we studied the effects of different chemotherapy molecules on our oxaliplatin-resistant cells to identify alternative treatments. Among all the studied molecules, gemcitabine was the only one to present a major cytotoxic effect on oxaliplatin-resistant cancer cells both in vivo and in vitro. However, the combination of oxaliplatin and gemcitabine did not present any major interest. Indeed, the study of combination efficiency using Chou and Talalay’s method showed no synergy between oxaliplatin and gemcitabine. Using PamGene technology to decipher gemcitabine’s effects on oxaliplatin-resistant cells, we were able to show that gemcitabine counteracts chemoresistance by strongly inhibiting the Akt and src/p38 MAPK pathways, leading to apoptosis induction and cell death. In view of these results, gemcitabine could be an interesting alternative therapy for patients with colorectal cancer not responding to oxaliplatin-based protocols such as FOLFOX.
Fichier principal
Vignette du fichier
cancers-14-05894-v2.pdf (3.59 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03880356 , version 1 (20-06-2023)





Mathieu Chocry, Ludovic Leloup, Fabrice Parat, Mélissa Messé, Alessandra Pagano, et al.. Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer. Cancers, 2022, 14 (23), pp.5894. ⟨10.3390/cancers14235894⟩. ⟨hal-03880356⟩
48 View
10 Download



Gmail Facebook X LinkedIn More